The New WHO Classification of Lung Tumors

Lung Cancer Biomarker Testing Patterns Varied Widely in Japan

Patient Comment on Mobocertinib for Exon 20

Trastuzumab Deruxtecan Potential New Treatment Options for HER2+ NSCLC

Targeting KRAS in Lung Cancer: The Past, Present, and Future 

Mobocertinib May Offer Effective, Safe Treatment in NSCLC with EGFR Exon 20 Insertion Mutation

Envisioning A Tobacco-Free Generation

Controversy Regarding U.S. Marketing of New Heated Tobacco Product IQOS

Physician's Twitter Campaign Boosts UK Quit Smoking Efforts

Decade in Review: Changes in Smoking Behaviors Are Altering the Clinical Picture of Lung Cancer

Declaración de IASLC: dejar de fumar tras un diagnóstico de cáncer

Declaração da IASLC: cessação do tabagismo após o diagnóstico de câncer